Ronald J Biediger

USPTO Granted Patents = 25 (Patent Applications = 5)

CIPO Patents = 6 (Patent Applications = 6)

EPO Patents = 9 (Patent Applications = 11)

Average Co-Inventor Count = 6.2

ph-index = 7

Forward Citations = 163(Granted Patents)

Location History:

Tallahassee, FL (US) (1995)
Houston, TX (US) (1997 - 2022)

Company Filing History:

8 out of 796

Florida State University Research Foundation, Inc.

patents

5 out of 34

Texas Heart Institute

patents

4 out of 37

Texas Biotechnology Corporation

patents

4. 3 out of 9

Encysive Pharmaceuticals, Inc.

patents

5. 3 out of 3

Aviara Pharmaceuticals, Inc.

Texas Children's Hospital

patents

where one patent can have more than one assignee

Years Active: 1995-2022

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11312685 - Targeting nanoparticles (2022-04-26),

2. 10875875 - Propionic acid derivatives and methods of use thereof (2020-12-29),

3. 10494367 - Propionic acid derivatives and methods of use thereof (2019-12-03),

4. 10287264 - Agonists that enhance binding of integrin-expressing cells to integrin receptors (2019-05-14),

5. 10246451 - Propionic acid derivatives and methods of use thereof (2019-04-02),

6. 10071980 - Agonists that enhanced binding of integrin-expressing cells to integrin receptors (2018-09-11),

7. 10035784 - Agonists that enhanced binding of integrin-expressing cells to integrin receptors (2018-07-31),

8. 9512109 - Agonists that enhance binding of integrin-expressing cells to integrin receptors (2016-12-06),

9. 8178699 - Modulators of CCR9 receptor and methods of use thereof (2012-05-15),

10. 7812038 - Carboxylic acid derivatives that inhibit the binding of integrins to their receptors (2010-10-12),

11. 7579340 - Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists (2009-08-25),

12. 7288538 - Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists (2007-10-30),

13. 6972296 - Carboxylic acid derivatives that inhibit the binding of integrins to their receptors (2005-12-06),

14. 6861537 - Tricyclic and tetracyclic taxane intermediates (2005-03-01),

15. 6723711 - Propanoic acid derivatives that inhibit the binding of integrins to their receptors (2004-04-20),

Title: The Inventor Ronald J Biediger

Introduction: Ronald J Biediger is a renowned inventor based in Houston, Texas. He has made significant contributions to the field of innovations with his creative ideas and patented inventions.

Latest Patents: Ronald J Biediger holds several patents in various industries, including technology, healthcare, and consumer products. His latest patents focus on improving efficiency and enhancing user experience in everyday products.

Career Highlights: Throughout his career, Ronald J Biediger has been recognized for his innovative thinking and problem-solving skills. He has successfully brought several inventions to market, making a positive impact on people's lives.

Collaborations: Ronald J Biediger has collaborated with leading companies and research institutions to further develop his inventions and bring them to the market. His collaborative efforts have resulted in groundbreaking products that have revolutionized their respective industries.

Conclusion: In conclusion, Ronald J Biediger is a visionary inventor who continues to push the boundaries of innovation. His passion for creating solutions to everyday challenges has established him as a prominent figure in the world of inventions.

This text is generated by artificial intelligence and may not be accurate.